Clinical Trial Update: Providers for Smoking Prevention Programs

View source ↗

Summary

A completed NHLBI-supported trial update examines providers for smoking prevention programs, with a focus on cardiovascular disease risk reduction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Heart Disease Risk Reduction | Status: COMPLETED